Oak Ridge, TN, June 22, 2023 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced that Maxim Group LLC (“Maxim”), as Representative of several Underwriters of its previously announced secondary public offering have partially exercised their option to purchase an additional 54,339 Option Shares […]
Other News
Jubilant Radiopharma Introduces RUBY Mobile Solutions™
MONTREAL–(BUSINESS WIRE)–Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited, is pleased to announce the clearance by the FDA to use its RUBY Rubidium Elution System™ and RUBY-FILL® (Rubidium Rb82 generator) in mobile settings. RUBY-FILL is used for cardiac PET imaging under rest or pharmacologic stress conditions to […]
Caristo Diagnostics Applauds FDA Approval of Colchicine as First Anti-Inflammatory Drug for Cardiovascular Disease
Colchicine’s Approval Heightens the Need for Technologies Detecting Inflammation Specifically Related to Coronary Arteries OXFORD, England, June 22, 2023 /PRNewswire/ — Caristo Diagnostics Limited, a global leader in cardiac and vascular disease diagnostics and risk prediction, applauds the FDA’s decision to approve colchicine as first anti-inflammatory drug for cardiovascular disease. Caristo reaffirms its commitment […]
Volta Medical Announces Initiation of RESTART Clinical Trial for Treatment of Repeat Atrial Fibrillation
Interventional study to evaluate long term outcomes of Volta’s AI solution-supported ablation in recurrent-AF patients who failed previous ablation International, multi-center trial at 21 sites with results expected in 2025 MARSEILLE, France, June 22, 2023 (GLOBE NEWSWIRE) — Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions […]
Microbot Medical Expand IP protection in Japan
Received Grant of Protection for a Design Patent in Japan Covering its Innovative LIBERTY® Robotic Drive HINGHAM, Mass., June 22, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic surgical system, today announced the expansion of its global […]
Sensome and Asahi Intecc Forge Partnership to Develop Next-Generation Smart Guidewire and Transform Stroke Treatment
PARIS–(BUSINESS WIRE)–Pioneering smart medical device company, Sensome, and world-leading Japanese guidewire company, Asahi Intecc, are announcing today a collaboration to develop the next generation Clotild® Smart Guidewire, with Asahi Intecc taking on the manufacturing role for this groundbreaking device destined for the treatment of acute ischemic stroke. Acute ischemic stroke is […]
Philips and BIOTRONIK expand care for out-of-hospital cardiology labs with new strategic alliance
Alliance further strengthens Philips’ industry-leading SymphonySuite solution, a complete, integrated offering to support clinicians or hospitals to open and operate office-based labs and ambulatory surgery centers Addition of BIOTRONIK’s cardiovascular technologies and products to the Philips SymphonySuite device programs expands the volume of procedures clinicians can perform in out-of-hospital settings, […]
Qardio Introduces Revolutionary Livestream ECG Monitoring and Advances Healthcare
SAN FRANCISCO, June 21, 2023 /PRNewswire/ — Qardio, a leading innovator in healthcare technology, has proudly unveiled its groundbreaking Livestream solution suite, which includes continuous ECG, Blood Pressure, Pulse Oximetry (SPO2), Body Temperature, Weight, and Body Position monitoring, marking a significant leap forward in real-time virtual patient care. These cutting-edge real-time solutions have […]
BioCardia Announces FDA Completes Review of Proposed Adaptive Statistical Analysis Design for Ongoing CardiAMP Cell Therapy in Heart Failure Pivotal Study
SUNNYVALE, Calif., June 20, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that FDA Center for Biologics Evaluation and Research (CBER) has completed review of the CardiAMP Cell Therapy System adaptive statistical analysis design supplement […]
ZyVersa Therapeutics Announces a Publication in Journal of the American Heart Association Linking NLRP3 Inflammasomes with Calcification in Arteries of Patients with Peripheral Arterial Disease (PAD)
PAD, characterized by vascular inflammation and associated calcification, affects 8.5 million people in the United States and contributes to more than 50,000 limb amputations annually, yet there are no specific pharmacologic treatments ZyVersa is developing Inflammasome ASC Inhibitor IC 100 for numerous inflammatory diseases WESTON, Fla., June 20, 2023 (GLOBE […]
Recent
Accelerating Adoption of AI Reporting in Radiology Has Propelled Replacement of Legacy SR Integration Technology
FDA Grants Coredio Breakthrough Designation for AI Platform Bringing Advanced Heart Failure Assessment Beyond the Hospital
BioCardia Announces Japan PMDA Record Of Advice Supports Regulatory Submission For Approval Of CardiAMP Cell Therapy For Ischemic Heart Failure
Popular
- No commented posts yet